Leo Redmond biography
Leo Redmond serves as Chief Financial Officer of the Company. From January 2008 to March 2013, Mr. Redmond served as Chief Financial Officer and Secretary at Presidio Pharmaceuticals, a clinical-stage pharmaceutical company, and from March 2013 to July 2019, he served as President, CFO and Secretary of Presidio Pharmaceuticals. Mr. Redmond has also served as a member of the board of directors of Presidio Pharmaceuticals since 2011. From December 2000 to December 2007, Mr. Redmond was Senior Director of Finance at Genentech, Inc., a biotechnology company, which was acquired by Roche in March 2009. From July 2004 to December 2007 Mr. Redmond also served as the CFO and Secretary for the Genentech Foundation for Biomedical Sciences. Prior to joining Genentech, Mr. Redmond worked for the GTE Corporation in various financial roles. Mr. Redmond holds a Bachelor of Science degree, with a double major in Business Administration and Accounting, from the University of Kansas and an MBA from the UCLA Anderson School of Management.
What is the salary of Leo Redmond?
As the Chief Financial Officer of Allakos Inc, the total compensation of Leo Redmond at Allakos Inc is $5,066,700. There are 3 executives at Allakos Inc getting paid more, with Robert Alexander having the highest compensation of $12,559,300.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Leo Redmond's mailing address?
Leo's mailing address filed with the SEC is 975 ISLAND DRIVE, SUITE 201, , REDWOOD CITY, CA, 94065.
Insiders trading at Allakos Inc
Over the last 6 years, insiders at Allakos Inc have traded over $246,100,922 worth of Allakos Inc stock and bought 5,181,222 units worth $35,384,176 . The most active insiders traders include Paul Edward Walker, Group, Llc Green Jeremy Red..., and Daniel Janney. On average, Allakos Inc executives and independent directors trade stock every 43 days with the average trade being worth of $114,372. The most recent stock trade was executed by Harlan Baird Radford on 28 June 2024, trading 87,064 units of ALLK stock currently worth $87,935.
What does Allakos Inc do?
allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.
What does Allakos Inc's logo look like?
Allakos Inc executives and stock owners
Allakos Inc executives and other stock owners filed with the SEC include:
-
Robert Alexander,
Chief Executive Officer, Director -
Adam Tomasi,
President, Chief Operating Officer -
Henrik Rasmussen,
Chief Medical Officer -
Leo Redmond,
Chief Financial Officer -
Mark Asbury,
Chief Legal Officer and General Counsel -
Dr. Robert Alexander Ph.D.,
CEO & Director -
Dr. Adam L. Tomasi Ph.D.,
Pres & COO -
Dr. Henrik Sandvad Rasmussen,
Strategic Advisor -
Mark Asbury,
Chief Legal Officer & Gen. Counsel -
Daniel Janney,
Independent Chair of the Board -
Robert Andreatta,
Independent Director -
John McKearn,
Independent Director -
Paul Walker,
Independent Director -
Steven James,
Independent Director -
Dr. Craig Paterson M.D.,
Chief Medical Officer -
Alan Chang,
Director of Medical Affairs & Data Analytics -
Tim Varacek,
Chief Commercial Officer -
Dr. Sally D. Bolmer,
Sr. VP of Regulatory Affairs & Drug Devel. -
Dr. Ruby Casareno Ph.D.,
Sr. VP of Technical Operations -
Baird Radford III,
Chief Financial Officer -
Group, Llc Green Jeremy Red...,
-
Venture Fund Iii, L.P.River...,
-
Partners Viii, L.P.Alta Par...,
-
Neil Murray Hamilton Graham,
-
Amy L Ladd,
-
Dolca Thomas,
-
Partners Next Gen Fund I Ma...,
-
Peter A Hudson,
-
Robert J More,
-
Guy P Nohra,
10% owner -
Natalie C. Holles,
Director -
Partners Next Gen Fund I Ma...,
-
Margaret Nell Fitzgerald,
General Counsel and Secretary -
Craig A. Paterson,
Chief Medical Officer -
Everett Rand Sutherland,
Director -
Partners Management Viii, L...,
-
Chin Hyok Lee,
Chief Medical Officer -
Harlan Baird Radford,
Chief Financial Officer